United States: A Fraudulent Concealment Win Coupled with a Unfavorable Learned Intermediary Ruling

Last Updated: November 9 2016
Article by Michelle Yeary

Yesterday's case is a partially published decision about a partial reversal of a plaintiff verdict in California. So, we are only going to discuss select parts of the decision. It's a long one and there are large sections about plaintiff's counsel's misconduct during trial and excessive damage awards. It is also a joint medical malpractice and product liability case. So, when you strip away the rest, we get down to a handful of legal rulings that we are truly interested in.

The case is Bigler-Engler v. Breg, Inc., 2016 Ca. App. LEXIS 921 (Cal. App. Oct. 28, 2016) and involves the use of a cold therapy medical device, available only upon prescription. Plaintiff underwent arthroscopic knee surgery, following which her surgeon prescribed use of the device to aid in recovery. Id. at *5-6. Plaintiff rented the device from her surgeon's medical practice. Id. at *7. Upon discharge after surgery, plaintiff was advised to use the device at a certain temperature "as much as possible." Id. at *8. Plaintiff's use of the device and the instructions she received from her surgeon are explained in more detail in the opinion, but ultimately, plaintiff developed severe skin damage that required multiple plastic surgeries and scar reduction surgeries. Id. at *9-13.

Plaintiff file suit against her surgeon, the medical practice, and the device manufacturer. The jury found against the manufacturer on plaintiff's claims for design defect, failure to warn, and intentional concealment. Id. at *19. The jury also awarded punitive damages against the manufacturer on the intentional concealment claim. Id. On appeal, the court overturned the intentional concealment verdict, which also meant reversing the punitive damages verdict. But, the court upheld the trial court's decision not to instruct the jury on the learned intermediary doctrine finding it did not apply to a medical device intended to be operated directly by the patient.

Intentional Concealment: Under California law, the elements of a claim for intentional concealment are: "(1) the defendant must have concealed or suppressed a material fact, (2) the defendant must have been under a duty to disclose the fact to the plaintiff, (3) the defendant must have intentionally concealed or suppressed the fact with the intent to defraud the plaintiff, (4) the plaintiff must have been unaware of the fact and would not have acted as he did if he had known of the concealed or suppressed fact, and (5) as a result of the concealment or suppression of the fact, the plaintiff must have sustained damage." Id. at *62 (citation omitted). Defendant in this case challenged that there was no evidence to satisfy the second element, a duty to disclose.

For a duty to disclose to arise, there must be some relationship between the parties. It must be a direct relationship such as seller and buyer or doctor and patient. Or a contractual relationship. In other words, there needs to be a transaction between the plaintiff and the defendant for there to be a duty to disclose. Id. at *63-65. "Such a transaction must necessarily arise from direct dealings between the plaintiff and defendant, it cannot arise between the defendant and the public at large." Id. at *65. Clearly the device manufacturer never had such a relationship or transaction with plaintiff.

So, plaintiff tried to conflate intentional concealment and failure to warn. In response to the lack of a relationship, plaintiff pointed to a manufacturer's general duty to warn. Id. But that is a products liability duty, not a fraud duty. "Products liability law involves a set of circumstances, elements, and doctrines that are independent from, and not directly applicable to, fraud. The duties underlying each cannot simply be applied to the other." Id. at *65-66.

Plaintiff also argued that a duty to disclose may arise if the disclosure is necessary to correct misleading statements. But this duty also depends on the existence of a relationship or transaction that was missing in this case. Id. at *66. There is an exception to the relationship requirement where an affirmative statement is "so misleading." But again, the only affirmative statements plaintiff could point to were the warnings and instructions that accompanied the device. First, the court did not find that the warnings and instructions were direct statements to plaintiff. Id. at *67. In fact, defendant had updated its warnings at least twice since the particular device at issue was manufactured and defendant had no knowledge the device had been provided to plaintiff. Id. More importantly, even assuming the labeling was a direct statement to plaintiff, there was nothing about it that was so misleading as to give rise to a duty to disclose in the absence of a relationship. Id. at *68. While the specific injury sustained by plaintiff may not have been included in the warnings, which may be the basis for a failure to warn claim under products liability law, the instructions and warnings that were provided were not "misleading half-truths" that would support a fraud claim. "To hold otherwise would unduly conflate two distinct areas of law, products liability and fraud, and transform every instance of inadequate product warning into a potential claim for fraud." Id. at *69.

The court concluded that based on the all evidence, there was no set of circumstances under which plaintiff could establish a duty to disclose. So, the court not only reversed the verdict against the manufacturer, but also found in favor of the manufacturer. Id. at *72. Then, because the jury's punitive damage award was based only on the intentional concealment claim, it too was reversed. Id.

Learned Intermediary: The second significant products ruling isn't as favorable as the first. California has adopted the learned intermediary doctrine for prescription drugs and medical devices because for prescription drugs and devices "it is through the physician that a patient learns of the properties and proper use of the drug or [device]." Id. at *80. The court took note that the cases that apply the learned intermediary doctrine to devices in California all involved implantable devices, which by definition don't need to include patient instructions at all. Id. at *81. Using patient instructions as the litmus test, the court concluded that the learned intermediary doctrine does not apply to devices that "require the patient to use and apply the device themselves." Id. at *81.

We aren't buying the court's logic on this one. In the part of the opinion on intentional concealment, the court repeatedly elaborated on the lack of any relationship between the manufacturer and the plaintiff, including the lack of any direct statements from the manufacturer to the plaintiff and even any knowledge that the device was provided to plaintiff. So, how can the manufacturer have a direct duty to warn the plaintiff? The device had been sold to the medical practice years earlier and therefore, was completely out of the manufacturer's control when it was provided to plaintiff. The manufacturer had no ability to interact with the plaintiff, to provide instruction to the plaintiff, to even know which warnings and instructions were provided to the plaintiff. Indeed, the court's finding that it is easier to directly warn the patient regarding a device such as this because warnings can be affixed directly to the device, id. at *82, is contradicted by the fact, as the court noted, that the warnings with this particular device were several versions out-of-date. Warnings that accompany prescription drugs that are re-filled every few months are kept more up to date than the warnings on a medical device that is used by different patients over a course of many years.

Moreover, regardless of instructions for use such as how to position the device or set its temperature, the device was only available by prescription. Therefore, the physician still serves as the learned intermediary. The physician is in a better position to be aware of and to inform his patient of any known risks, especially as science is always evolving. So, while there is an avenue for providing product information, including risks and warnings, to the patient with the device, that is no different than providing risk and warning information inside pill bottles or affixed to medications by pharmacies. It does not create a direct relationship between the manufacturer and the patient. And, we are still talking about highly technical information that would be difficult for a lay person to understand if not explained by a doctor. Are we expecting the average person to understand about vasoconstriction and its potential complications? If plaintiff was alleging her injury was caused because the device did not come with adequate instructions for how to set the temperature, we might see some basis for the court's decision (we still wouldn't agree with it, but we'd find it easier to understand). But, failure to warn about the medical risks of prolonged exposure, that belongs squarely in the learned intermediary doctrine.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.